Author:
Gietema J.A,Groen H.J.M,Meijer S,Smit E.F
Reference12 articles.
1. Preclinical in vivo activity of 2,2-difluorodeoxycytidine (gemcitabine) against human head and neck cancer;Braakhuis;Cancer Res,1991
2. Evaluation of the antitumour activity of gemcitabine, (difluoro-2-deoxycytidine);Hertel;Cancer Res,1990
3. Phase I clinical trials of gemcitabine as an intravenous bolus on 5 consecutive days;O Rourke;Eur J Cancer,1994
4. Difluorodeoxycytidine (dFdC)-gemcitabine: a phase I study;Poplin;Invest New Drugs,1992
5. Abruzzese JL, Grunewald R, Weeks EA, et al. A phase I clinical plasma and cellular pharmacology study of gemcitabine. J Clin Oncol 1991, 12, 491–498.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献